0000899243-18-016875.txt : 20180615 0000899243-18-016875.hdr.sgml : 20180615 20180615213835 ACCESSION NUMBER: 0000899243-18-016875 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180615 FILED AS OF DATE: 20180615 DATE AS OF CHANGE: 20180615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ho Tony W CENTRAL INDEX KEY: 0001713637 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37923 FILM NUMBER: 18903485 MAIL ADDRESS: STREET 1: CRISPR THERAPEUTICS AG STREET 2: 610 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CRISPR Therapeutics AG CENTRAL INDEX KEY: 0001674416 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 473173478 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 BUSINESS PHONE: 6173154600 MAIL ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-06-15 0 0001674416 CRISPR Therapeutics AG CRSP 0001713637 Ho Tony W C/O CRISPR THERAPEUTICS, INC. 610 MAIN ST. CAMBRIDGE MA 02139 0 1 0 0 See Remarks Stock Option (Right to Buy) 59.31 2018-06-15 4 A 0 43000 0.00 A 2028-06-15 Common Shares 43000 43000 D This option was granted on June 15, 2018 with respect to 43,000 Common Shares with 100% of the shares vesting in 48 equal monthly installments. Executive Vice President, Head of Research & Development /s/ Michael Esposito, attorney-in-fact 2018-06-15